ST
Sarepta Therapeutics Inc
🇩🇪XSTU.AB3AGermanyHealthcare
€17.30EURdown -0.70 (-3.89%)ClosedEnd of day2:46 AM
Price€17.30-0.70 (-3.89%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US8036071004
- CUSIP
- Not reported
Company
- Employees
- 835
- Headquarters
- Cambridge, United States
- Website
- https://www.sarepta.com
- CEO
- Dr. Michael E. Severino M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.97B-20.44%down year on year
- Net income
- -$136.73M-135.91%down year on year
- Gross margin
- 58.56%-26.14%down year on year
- Free cash flow
- -$131.47M+71.04%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.